Highlights Bio-View Ltd

Equities

BIOV

IL0010960495

Advanced Medical Equipment & Technology

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 05:56:58 2026-03-09 am EDT			5-day change	1st Jan Change
16.90 ^ILa	-1.17%		+4.97%	+1.20%

Dec. 30	An undisclosed buyer signed share sale agreement to acquire 20.97% stake in Bio-View Ltd from Emmanuel Gill for ILS 6.1 million.	CI
25-08-25	Bio-View Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Highlights

Dec. 30	An undisclosed buyer signed share sale agreement to acquire 20.97% stake in Bio-View Ltd from Emmanuel Gill for ILS 6.1 million.	CI
25-08-25	Bio-View Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-03-23	Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-12-18	Bioview Ltd. Presents Promising Results from Their Joint Liquid Biopsy Development Project	CI
24-08-19	Bio-View Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-08-18	Bio-View Ltd announces an Equity Buyback for ILS 0.7 million worth of its shares.	CI
24-08-17	Bio-View Ltd authorizes a Buyback Plan.	CI
24-03-27	Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-27	Bio-View Ltd announces an Equity Buyback for ILS 0.7 million worth of its shares.	CI
24-03-26	Bio-View Ltd authorizes a Buyback Plan.	CI
23-08-22	Tranche Update on Bio-View Ltd's Equity Buyback Plan announced on March 27, 2023.	CI
23-08-20	Bio-View Ltd's Equity Buyback announced on March 27, 2023 has closed with 247,356 shares, representing 1.79% for ILS 0.87 million.	CI
23-08-14	Bio-View Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-03-27	Bio-View Ltd announces an Equity Buyback for ILS 0.87 million worth of its shares.	CI
23-03-27	Tranche Update on Bio-View Ltd's Equity Buyback Plan announced on November 30, 2022.	CI
23-03-27	Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-25	Bio-View Ltd authorizes a Buyback Plan.	CI
23-02-27	Bio-View Ltdâ€™s Equity Buyback announced on November 30, 2022, has expired with 303,378 shares, representing 2.09% for ILS 1.13 million.	CI
21-05-26	Bio-View Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW